No record found
No record found
No record found
capitalstake.com. Provided by * Returns not adjusted for payouts
^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.
Company Profile
Highnoon Laboratories Limited (“the Company”) was incorporated in Pakistan under the repealed Companies Ordinance 1984 (now Companies Act, 2017) (“the Act”) and its shares are quoted on Pakistan Stock Exchange since November 1994. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and related consumer products. The registered office of the Company is situated at 17.5 km, Multan Road, Lahore.
| Dr. Adeel Abbas Haideri | CEO |
| Tariq Wajid | Chairperson |
| Baqar Hasan | Company Secretary |
Corplink (Pvt.) Ltd. Wings Arcade, 1-K Commercial, Model Town, Lahore.
M/s BDO Ebrahim & Co. Chartered Accountants
December
Equity Profile
Announcements
| Date | Title | Document |
|---|---|---|
| Apr 30, 2026 | Transmission of Quarterly Report for the Period Ended 31.03.2026 | View PDF |
| Apr 29, 2026 | Financial Results for the Quarter Ended 31.03.2026 | View PDF |
| Apr 10, 2026 | Transmission of Annual Report for the Year Ended 31 December 2025 | View PDF |
| Apr 7, 2026 | HINOON | Highnoon Laboratories Limited Financial Results for the Year Ended December 31, 2025 | |
| Oct 30, 2025 | Transmission of Quarterly Report for the Period Ended 30.09.2025 | View PDF |
| Date | Title | Document |
|---|---|---|
| Apr 30, 2026 | Certified Copies of Resolutions passed at the 43rd Annual General Meeting of Highnoon Laboratories Limited held on 30th April 2026 | View PDF |
| Apr 22, 2026 | Board Meeting | View PDF |
| Apr 8, 2026 | Notice of Annual General Meeting | View PDF |
| Apr 7, 2026 | Board Meeting in Progress | View PDF |
| Apr 6, 2026 | Board Meeting in Progress | View PDF |
| Date | Title | Document |
|---|---|---|
| May 5, 2026 | Video Recording of Corporate Briefing Session Highnoon Laboratories Limited | View PDF |
| May 4, 2026 | Revised Presentation of Corporate Briefing Session | View PDF |
| Apr 29, 2026 | Corporate Briefing Session -Highnoon Laboratories Limited | View PDF |
| Apr 27, 2026 | Notice of Corporate Briefing Session -Highnoon Laboratories Limited | View PDF |
| Apr 10, 2026 | Statement of Material Facts under 134 (3) | View PDF |
Financials
All numbers in thousands (000's) except EPS
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 25,789,242 | 23,195,152 | 19,424,255 | 15,815,937 |
| Profit after Taxation | 4,119,313 | 3,253,501 | 2,403,014 | 2,417,172 |
| EPS | 77.75 | 61.41 | 45.35 | 45.62 |
| Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | |
|---|---|---|---|---|
| Sales | 6,813,970 | 6,575,586 | 5,491,013 | 6,548,244 |
| Profit after Taxation | 955,684 | 1,001,079 | 743,515 | 915,641 |
| EPS | 18.04 | 18.89 | 13.43 | 17.28 |

Ratios
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Gross Profit Margin (%) | 54.78 | 51.43 | 47.64 | 50.77 |
| Net Profit Margin (%) | 15.97 | 14.03 | 12.37 | 15.28 |
| EPS Growth (%) | 26.61 | 35.41 | (0.59) | 5.68 |
| PEG | 0.49 | 0.42 | (18.80) | 2.09 |









Feedback
Terms of Use
https://www.psx.com.pk